New biosensor technology could revolutionize mpox diagnosis

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

A new variant of human mpox has claimed the lives of approximately 5% of people with reported infections in the Democratic Republic of the Congo since 2023, many of them children. Since then, it has spread to several other countries.